Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAGSHIP: AQX-1125 for COPD
NCT01954628Phase 2Completed
- Sponsor
- Aquinox Pharmaceuticals
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of rosiglitazone in chronic obstructive pulmonary disease (COPD), sponsored by Aquinox Pharmaceuticals. Started Oct 2013; status: completed.
02
Drugs
rosiglitazone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01954628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01954628.